Class / Patent application number | Description | Number of patent applications / Date published |
564355000 | Hydroxy, bonded directly to carbon, or ether oxygen attached directly or indirectly to the acyclic carbon or chain by acyclic nonionic bonding with no amino nitrogen between the hydroxy or ether oxygen and the aryl ring or ring system (H of -OH may be replaced by a substituted or unsubstituted ammonium ion or a Group IA or IIA light metal) | 22 |
20080221356 | Processes for the synthesis of O-desmethylvenlafaxine - The present invention describes processes for the preparation of O-desmethylvenlafaxine and tridesmethylvenlafaxine, which may be used as an intermediate in preparing O-desmethylvenlafaxine. | 09-11-2008 |
20080275272 | AMINE COMPOUNDS AND INHIBITING NEUROTRANSMITTER REUPTAKE - The invention relates to amine compounds as well as methods and materials involved in modulating neurotransmitter reuptake. Specifically, the invention provides amine compounds, methods for synthesizing amine compounds, and methods for inhibiting neurotransmitter reuptake. | 11-06-2008 |
20090018365 | Methods for Preparing O-Desmethylvenlafaxine - The present invention provides an efficient method of making O-desmethyl-venlafaxine. | 01-15-2009 |
20090069601 | Processes for the synthesis of O-desmethylvenlafaxine - The present invention describes processes for the preparation of O-desmethylvenlafaxine and tridesmethylvenlafaxine, which may be used as an intermediate in preparing O-desmethylvenlafaxine. | 03-12-2009 |
20090292142 | Substantially pure O-desmethylvenlafaxine and processes for preparing it - Methods for preparing substantially pure O-desmethylvenlafaxine are described. | 11-26-2009 |
20100099916 | Process for the Preparation of (1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol - The present invention relates to a process for the preparation of (1R,2R)- | 04-22-2010 |
20120078016 | Methods of Synthesizing 2-Substituted-1,4-Benzenediamine - Disclosed is a method of making a 2-substituted-1,4-benzenediamine by nucleophilic aromatic substitution. | 03-29-2012 |
20120108848 | PROCESS FOR RESOLUTION OF 1-(3-HYDROXYPHENYL)-2-METHYLAMINO ETHANOL - Resolution of the title compound to its active isomer (R)-1-(3-hydroxyphenyl)-2-methylamino ethanol with (R)-naproxen as a resolving agent. | 05-03-2012 |
564356000 | Preparing directly by reduction, other than by reductive amination | 7 |
20090137846 | Processes for the synthesis of O-Desmethylvenlafaxine - The present invention describes processes for the preparation of O-desmethylvenlafaxine and tridesmethylvenlafaxine, which may be used as an intermediate in preparing O-desmethylvenlafaxine. | 05-28-2009 |
20100286447 | PROCESS FOR PRODUCING 1-[2-(DIMETHYLAMINO)-1-(4-PHENOL)ETHYL]CYCLOHEXANOL - The present invention relates to an improved, process for large scale production of 1-[2-(dimethylamino)-1-(4-phenol)ethyl]cyclohexanol (O-desmethylvenlafaxine) or its pharmaceutically acceptable salts with increased yield and minimal impurities. | 11-11-2010 |
20110152574 | Novel diamino-alcohol compounds and processes for their manufacture - A new class of compounds, namely diamino alcohols, is described, along with a process for their production and their use as dispersing additives for coating formulations. | 06-23-2011 |
20140094625 | Process - The present invention relates to improved processes for the production of 2-amino-2-[2-(4-C | 04-03-2014 |
20140235895 | PREPARATION OF FINGOLIMOD AND ITS SALTS - The present application provide processes for the preparation of fingolimod and its pharmaceutically acceptable salts, process for the purification of fingolimod hydrochloride and process for the preparation of amorphous fingolimod hydrochloride. | 08-21-2014 |
564357000 | By direct hydrogenation | 2 |
20130123539 | METHODS FOR PREPARING RITODRINE HYDROCHLORIDE - Methods for preparing Ritodrine hydrochloride are provided. Also provided is non-hygroscopic, crystalline, polymorphic Ritodrine hydrochloride of Form I. | 05-16-2013 |
564358000 | Group VIII noble metal containing catalyst utilized | 1 |
20100152490 | Process Of Racemisation Of Optically Active Alpha Aminoacetals - The invention relates to a process for preparing α-aminoacetals substantially in racemic form, comprising a step of oxidizing optically enriched α-aminoacetals to the corresponding oximes, in the presence of a catalyst, and a step of reducing the oximes thus obtained. | 06-17-2010 |
564359000 | Preparing directly by hydrolysis | 1 |
20090312578 | PREPARATION OF (2R,3R)-3-(3-METHOXYPHENYL)-N,N,2-TRIMETHYLPENTANAMINE - The present invention relates to an improved process for the preparation of (2R,3R)-3-(3-methoxyphenyl)-N,N,2-trimethylpentanamine which is an intermediate for the preparation of the analgesic tapentadol. | 12-17-2009 |
564360000 | Additional hydroxy, bonded directly to carbon, or ether oxygen attached directly or indirectly to the acyclic carbon or chain by acyclic nonionic bonding with no amino nitrogen between the additional hydroxy or ether oxygen and the aryl ring or ring system (H of -OH may be replaced by a substituted or unsubstitited ammonium ion or a Group IA or IIA light metal) | 5 |
20090240082 | Processes for Preparing Venlafaxine and Venlafaxine Hydrochloride of Form I - A process for preparing venlafaxine in a high yield as well as processes for producing venlafaxine hydrochloride of form I having a very hight polymorphic purity are described. | 09-24-2009 |
20100191015 | PROCESS FOR THE PREPARATION OF O-DESMETHYLVENLAFAXINE SUCCINATE POLYMORPHIC FORMS - The present invention relates to process for the preparation of novel crystalline Desmethylvenlafaxine succinate polymorphic Forms-A, B. The present invention also relates to novel processes for the preparation of 0-Desmethylvenlafaxine succinate polymorphic Forms-(I), (II), (III) and amorphous. | 07-29-2010 |
20130281739 | FINGOLIMOD POLYMORPHS AND THEIR PROCESSES - The present invention provides crystalline polymorphic forms of Fingolimod HCl (I) and processes for preparation thereof. | 10-24-2013 |
20140066657 | DOSAGE REGIMEN FOR A S1P RECEPTOR AGONIST - S1P receptor modulators or agonists are administered following a dosage regimen whereby during the initial days of treatment the daily dosage is lower than the standard daily dosage | 03-06-2014 |
20150344409 | PROCESS FOR THE PREPARATION OF FINGOLIMOD AND ITS SALTS - The present invention provides process for preparation of Fingolimod hydrochloride (I). | 12-03-2015 |
564363000 | Beta hydroxy phenethylamines (i.e., hydroxy and the benzene ring are bonded directly to the same carbon of the chain which consists of two carbons; H of -OH may be replaced by a substituted or unsubstituted ammonium ion or a Group IA or IIA light metal) | 1 |
20090112025 | CATALYTIC HYDROGENATION PROCESS AND NOVEL CATALYST FOR IT - The present invention provides a novel hydrogenation catalyst, process of preparing the catalyst and process for the preparation of optically active L-norephedrine, [(1R,2S)-2-amino-1-phenyl-1-propanol] by a catalytic hydrogenation process, said catalyst comprising of finely divided nickel metal containing a metal from group III A of the periodic table as an activator and a metal from group VI B or VIII as promoter, | 04-30-2009 |